Literature DB >> 2992737

Insulinoma. An immunocytochemical and morphologic analysis of 95 cases.

T H Liu, H C Tseng, Y Zhu, S X Zhong, J Chen, Q C Cui.   

Abstract

One hundred twenty-seven insulinomas from 95 cases (1 malignant and 94 benign) were studied pathologically. Thirty-six tumors (35 cases) were examined by electron microscopy. Typical beta-cell secretory granules of crystalloid-form cores and/or atypical secretory granules were discerned in all tumors examined. A new type of secretory granule, with high electron-dense crystalloid-form cores and moderate electron-dense granular substance filling the space between the core and the limiting membrane, were observed in two cases. Among 68 insulinomas (67 cases) subjected to immunocytochemical investigations with ten peptide hormones (insulin, glucagon, somatostatin, pancreatic polypeptide (PP), gastrin, motilin, secretin, vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and neurotensin), 42 were found to be multihormonal, varying from two to four peptides secreted. The hormones contained were insulin, glucagon, PP, somatostatin, and gastrin in different combinations. One patient had hyperinsulinemia and hypergastrinemia concurrently, and two islet tumors were excised at an interval of 10 months. Both electron microscopy and immunocytochemistry confirmed the presence of beta- and alpha-cells in the first tumor, whereas the second tumor revealed only G-cells by electron microscopy, and G- and beta-cells on immunocytochemical staining. The morphologic and immunocytochemical characteristics of the insulinomas in this series are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992737     DOI: 10.1002/1097-0142(19850915)56:6<1420::aid-cncr2820560633>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth.

Authors:  R F Power; R Holm; A E Bishop; I M Varndell; S Alpert; D Hanahan; J M Polak
Journal:  Gut       Date:  1987       Impact factor: 23.059

2.  Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects.

Authors:  H Toshimori; R Narita; M Nakazato; J Asai; T Mitsukawa; K Kangawa; H Matsuo; K Takahashi; S Matsukura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Multihormonality and entrapment of islets in pancreatic endocrine tumors.

Authors:  Y Kapran; J Bauersfeld; M Anlauf; B Sipos; G Klöppel
Journal:  Virchows Arch       Date:  2006-01-18       Impact factor: 4.064

Review 4.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

6.  Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis.

Authors:  Nobuyuki Ohike; Toshio Morohoshi
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

7.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

8.  Comparison between liver and serum concentrations of mannan binding protein.

Authors:  N G Ryley; A R Heryet; J Lu; K B Reid; K A Fleming
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

9.  Malignant insulinoma with metastasis to gallbladder and bone, accompanied by past history of peptic ulcer and hyperthyroidism.

Authors:  M Imamura; E Miyashita; K Miyagawa; S Matsuno; T Sato
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

10.  Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.

Authors:  K Yamaguchi; M Enjoji
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.